Drugs / ARD-0403
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00597051 | Oct 2005 → Feb 2006 | hypogonadism | Ardana Bioscience Ltd | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT00562731 | Oct 2007 → Jun 2008 | hypogonadism | Ardana Bioscience Ltd | Terminated | No outcome recorded Stop: Business |
| Phase 3 | NCT00448955 | May 2007 → Feb 2008 | hypogonadism | Ardana Bioscience Ltd | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ARD-0403 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00597051 ↗ |